Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis.
van Zandvoort LJC, van Bommel RJ, Masdjedi K, Tovar Forero MN, Lemmert MM, Wilschut J, Diletti R, de Jaegere PPT, Zijlstra F, van Mieghem NM, Daemen J. van Zandvoort LJC, et al. Among authors: diletti r. Catheter Cardiovasc Interv. 2020 May 1;95(6):1085-1091. doi: 10.1002/ccd.28387. Epub 2019 Jul 13. Catheter Cardiovasc Interv. 2020. PMID: 31301161
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.
Brugaletta S, Garcia-Garcia HM, Garg S, Gomez-Lara J, Diletti R, Onuma Y, van Geuns RJ, McClean D, Dudek D, Thuesen L, Chevalier B, Windecker S, Whitbourn R, Dorange C, Miquel-Hebert K, Sudhir K, Ormiston JA, Serruys PW. Brugaletta S, et al. Among authors: diletti r. Int J Cardiovasc Imaging. 2011 Jul;27(6):859-66. doi: 10.1007/s10554-010-9724-y. Epub 2010 Oct 13. Int J Cardiovasc Imaging. 2011. PMID: 20941544 Free article. Clinical Trial.
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.
Gomez-Lara J, Brugaletta S, Diletti R, Garg S, Onuma Y, Gogas BD, van Geuns RJ, Dorange C, Veldhof S, Rapoza R, Whitbourn R, Windecker S, Garcia-Garcia HM, Regar E, Serruys PW. Gomez-Lara J, et al. Among authors: diletti r. Eur Heart J. 2011 Feb;32(3):294-304. doi: 10.1093/eurheartj/ehq458. Epub 2010 Dec 1. Eur Heart J. 2011. PMID: 21123276 Free article.
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study.
Brugaletta S, Garcia-Garcia HM, Diletti R, Gomez-Lara J, Garg S, Onuma Y, Shin ES, van Geuns RJ, de Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Dorange C, Veldhof S, Rapoza R, Sudhir K, Bruining N, Ormiston JA, Serruys PW. Brugaletta S, et al. Among authors: diletti r. EuroIntervention. 2011 Apr;6(9):1110-6. doi: 10.4244/EIJV6I9A193. EuroIntervention. 2011. PMID: 21518685 Clinical Trial.
Agreement and reproducibility of gray-scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold.
Gómez-Lara J, Brugaletta S, Diletti R, Gogas BD, Farooq V, Onuma Y, Gobbens P, Van Es GA, García-García HM, Serruys PW. Gómez-Lara J, et al. Among authors: diletti r. Catheter Cardiovasc Interv. 2012 May 1;79(6):890-902. doi: 10.1002/ccd.23108. Epub 2011 Nov 30. Catheter Cardiovasc Interv. 2012. PMID: 21523891 Clinical Trial.
Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: insights from the ABSORB and SPIRIT trials.
Brugaletta S, Gomez-Lara J, Diletti R, Farooq V, van Geuns RJ, de Bruyne B, Dudek D, Garcia-Garcia HM, Ormiston JA, Serruys PW. Brugaletta S, et al. Among authors: diletti r. Catheter Cardiovasc Interv. 2012 Feb 1;79(2):219-28. doi: 10.1002/ccd.22996. Epub 2011 May 11. Catheter Cardiovasc Interv. 2012. PMID: 21563288 Clinical Trial.
NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography.
Brugaletta S, Garcia-Garcia HM, Serruys PW, de Boer S, Ligthart J, Gomez-Lara J, Witberg K, Diletti R, Wykrzykowska J, van Geuns RJ, Schultz C, Regar E, Duckers HJ, van Mieghem N, de Jaegere P, Madden SP, Muller JE, van der Steen AF, van der Giessen WJ, Boersma E. Brugaletta S, et al. Among authors: diletti r. JACC Cardiovasc Imaging. 2011 Jun;4(6):647-55. doi: 10.1016/j.jcmg.2011.03.013. JACC Cardiovasc Imaging. 2011. PMID: 21679900 Free article.
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm.
Diletti R, Onuma Y, Farooq V, Gomez-Lara J, Brugaletta S, van Geuns RJ, Regar E, de Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Smits P, Koolen J, Meredith I, Li D, Veldhof S, Rapoza R, Garcia-Garcia HM, Ormiston JA, Serruys PW. Diletti R, et al. J Am Coll Cardiol. 2011 Jul 12;58(3):258-64. doi: 10.1016/j.jacc.2011.02.052. J Am Coll Cardiol. 2011. PMID: 21737016 Free article.
215 results